Evaluation of a Patient-Reported Symptom Index for NMIBC
Completed
Conditions studied: Superficial Bladder Cancer
In brief
This project will develop and evaluate a patient-reported symptom index to assess the impact of treatment for non-muscle invasive bladder cancer on patient burden, toxicity, symptoms and side effects. The symptom index will provide a method for assessing treatments from the patient's perspective; help healthcare professionals make better informed treatment decisions, and provide a method to be able to effectively evaluate treatments for non-muscle invasive bladder cancer.
Key facts
- Study ID
- NCT03091764
- Run by
- University of Sydney
- People needed
- 498
- Starts
- 2016-07-01
- Expected to finish
- 2021-08-30
- Last updated by the study team
- 2021-10-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosed NMIBC
- Adult (>18yrs)
- able to read and understand English
- undergoing active treatment (i.e. one week after tumour resection or intravesical therapy) or completed final treatment for NMIBC within the last week
You may not qualify if…
- unconscious or confused
- have cognitive impairment
- unable to speak, read and/or write in English
- diagnosed with muscle invasive disease
- unable to provide informed consent
- Field test 2:
- Inclusion Criteria:
- newly diagnosed NMIBC
- Adult (>18yrs)
- able to read and understand English
- after imaging or flexible cystoscopy, and before active treatment
- either before endoscopic resection, or more than 4 weeks since endoscopic resection, but before active/ongoing treatment
- Exclusion Criteria:
- unconscious or confused
- have cognitive impairment
- unable to speak, read and/or write in English
- diagnosed with muscle invasive disease
- unable to provide informed consent
- currently undergoing active treatment for any bladder cancer, or finished treatment within last 3 years.
Where it is running
- University of Kansas — Kansas City, Kansas, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Concord Hospital — Concord, New South Wales, Australia
- Royal North Shore Hospital — St Leonards, New South Wales, Australia
- Riverina Cancer Care Centre — Wagga Wagga, New South Wales, Australia
- The Urological Cancer Centre, Westmead Specialist Centre — Westmead, New South Wales, Australia
- Westmead Hospital — Westmead, New South Wales, Australia
- Mater Misericordiae Limited — South Brisbane, Queensland, Australia
- Box Hill Hospital — Box Hill, Victoria, Australia
- Austin Health — Heidelberg, Victoria, Australia
- Alfred Health — Melbourne, Victoria, Australia
- Monash Health — Moorabbin, Victoria, Australia
- Royal Melbourne Hospital — Parkville, Victoria, Australia
- Fiona Stanley Hospital — Murdoch, Western Australia, Australia
- University of British Columbia — Vancouver, British Columbia, Canada
- Canterbury Urology Research Trust — Christchurch, New Zealand
- Tauranga Urology Research — Tauranga, New Zealand
- Salford Royal NHS Foundation Trust — Salford, Manchester, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.